TIMOTHY HURLBURT: Open Payments
NPI 1336699875 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 26 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $387 |
| GENZYME CORPORATION | 10 | $347 |
| GlaxoSmithKline, LLC. | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Genentech USA, Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, TUDORZA PRESSAIR, Xolair.
Industry payments across MA — which companies pay providers there.
